Gene · 440
Papers1,669
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,669
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development. | J Oncol | 2022 | 36072981 | PubTator, text mining | PubMed |
| Integrative multi-omics landscape of fluoxetine action across 27 brain regions reveals global increase in energy metabolism and region-specific chromatin remodelling. | Mol Psychiatry | 2022 | 36056172 | PubTator, text mining | PubMed |
| ASNS can predict the poor prognosis of clear cell renal cell carcinoma. | Front Oncol | 2022 | 36052245 | PubTator, text mining | PubMed |
| Analysis of the Prognostic Significance and Immune Infiltration of the Amino Acid Metabolism-Related Genes in Colon Adenocarcinoma. | Front Genet | 2022 | 36035152 | PubTator, text mining | PubMed |
| A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer. | Front Endocrinol (Lausanne) | 2022 | 36034466 | PubTator, text mining | PubMed |
| Analysis of gene expression in monocytes of immunized pigs after infection with homologous or heterologous African swine fever virus. | Front Vet Sci | 2022 | 36032295 | PubTator, text mining | PubMed |
| A Proteomic Approach to Study the Biological Role of Hepatitis C Virus Protein Core+1/ARFP. | Viruses | 2022 | 36016316 | PubTator, text mining | PubMed |
| Cellular and molecular characterization of two novel asparagine synthetase gene mutations linked to asparagine synthetase deficiency. | J Biol Chem | 2022 | 35985424 | Swiss-Prot, curated | PubMed |
| Palmitate and thapsigargin have contrasting effects on ER membrane lipid composition and ER proteostasis in neuronal cells. | Biochim Biophys Acta Mol Cell Biol Lipids | 2022 | 35981704 | PubTator, text mining | PubMed |
| An induced-fit model for asymmetric organocatalytic reactions: a case study of the activation of olefins via chiral Brønsted acid catalysts. | Chem Sci | 2022 | 35975151 | PubTator, text mining | PubMed |
| The diverse functions of FAT1 in cancer progression: good, bad, or ugly? | J Exp Clin Cancer Res | 2022 | 35965328 | PubTator, text mining | PubMed |
| The Differential Metabolic Signature of Breast Cancer Cellular Response to Olaparib Treatment. | Cancers (Basel) | 2022 | 35954325 | PubTator, text mining | PubMed |
| Untargeted Metabolomics and Transcriptomics Reveal the Mechanism of Metabolite Differences in Spring Tender Shoots of Tea Plants of Different Ages. | Foods | 2022 | 35954069 | PubTator, text mining | PubMed |
| MYC sensitises cells to apoptosis by driving energetic demand. | Nat Commun | 2022 | 35945217 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| The involvement of gut microbiota in the anti-tumor effect of carnosic acid via IL-17 suppression in colorectal cancer. | Chem Biol Interact | 2022 | 35926579 | PubTator, text mining | PubMed |
| Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells. | Cell Death Dis | 2022 | 35922423 | PubTator, text mining | PubMed |
| Argininosuccinate synthase 1, arginine deprivation therapy and cancer management. | Front Pharmacol | 2022 | 35910381 | PubTator, text mining | PubMed |
| Anticancer Properties of N,N-dibenzylasparagine as an Asparagine (Asp) analog, Using Colon Cancer Caco-2 Cell Line. | Asian Pac J Cancer Prev | 2022 | 35901362 | PubTator, text mining | PubMed |
| Identification of Endoplasmic Reticulum Stress-Related Subtypes, Infiltration Analysis of Tumor Microenvironment, and Construction of a Prognostic Model in Colorectal Cancer. | Cancers (Basel) | 2022 | 35884393 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/440/papers?page=20